Magnetic Resonance Imaging Tissue Feature Tracking for Cardiac Amyloidosis

WANG Zhe-tao, WANG Chun-hua, CHEN Yu-shu, SUN Jia-yu, ZHU Tong, ZHANG Yu, GAO Fa-bao

Abstract

To detect cardiac amyloidosis (CA) using cardiac magnetic resonance feature tracking(CMR-FT).  Methods  Forty-three CA patients and 24 healthy volunteers underwent steady-state free precession cine sequence on 3.0T MRI after injection of Magnevist. Software cvi 42 was used for analyzing the left ventricular function including left ventricular mass (diastole) (LVMD), left ventricular mass (systole) (LVMS), left ventricle end-diastolic volume (LVEDV), left ventricle end-systolic volume (LVESV), left ventricle stroke volume (LVSV), and left ventricular ejection fraction (LVEF), as well as myocardial strains including 3D global longitudinal strain (GLS), global circumferential strain (GCS), and global radial strain (GRS), and 2D endocardial and epicardial longitudinal strain, circumferential strain, and radial strain (ENDO-LS, EPI-LS, ENDO-CS, EPI-CS, ENDO-RS, and EPI-RS). The global and layer-specific strains were compared between the CA patients with LVEF >50%, the CA patients with LVEF ≤50%, and the healthy controls.  Results  For the left ventricular function, the CA patients had greater myocardial mass than the healthy controls (P < 0.05); the CA patients with LVEF ≤50% had greater LVESV and lower LVSV than those with LVEF >50% (P < 0.05). For the global strains, significant differences also appeared in GLS and GCS among the three groups (all P < 0.05). The CA patients had lower GRS than the healthy controls (P < 0.05), while no significant difference was found in GRS between the CA patients with LVEF >50% and those with LVEF ≤50% (P>0.05). For the layer-specific strains, significant differences in ENDO-LS, EPI-LS, ENDO-CS, EPI-CS, ENDO-RS, and EPI-RS were found among the three groups (all P < 0.05). There were significant correlations between GLS and LVEF (r=-0.404, P=0.016), and between GCS and LVEF (r=-0.602, P < 0.001) in the CA patients.  Conclusion  CMR-FT can assess not only global strains but also layer-specific strains for the myocardial function of CA patients.

 

Keywords: CMR-FT, Cardiac amyloidosis, Myocardial strain, Endocardium, Epicardium

 

Full Text:

PDF


References


RAPEZZI С, MERLINI G, QUARTA CC, et al. Systemic cardiac amyloidoses; disease profiles and clinical courses of the 3 main types. Circulation,2009,120( 13): 1203-1212. MERLINI G, BELLOTTI V. Molecular mechanisms of amyloidosis. NEJM, 2003,349(6); 583-596.

WAN K, SUN J, YANG D, et al. Left ventricular myocardial deformation on cine MR images; relationship to severity of disease and prognosis in light-chain amyloidosis. Radiology ,2018,288(1); 73-80.

BARREIRO-PEREZ M, CURIONE D. SYMONS R, et al. Left ventricular global myocardial strain assessment comparing the reproducibility of four commercially available CMR-feature tracking algorithms. Eur Radiol.2018,28( 12): 5137-5147.

SCHUSTER A, HOR KN, KOWALLICK JT, et al. Cardiovascular magnetic resonance myocardial feature tracking; concepts and clinical applications. Circ Cardiovasc Imaging,2016, 9 ( 4 ) s e004077 [2019-04-07]. https://doi. org/10. 1161/CIRCIMAGING. 115.004077

TADIC M, PIESKE-KRAIGHER E, CUSPIDI C, et al. Left ventricular strain and twisting in heart failure with preserved ejection fraction; an updated review. Heart Fail Rev,2017,22(3):371-379.

MALESZEWSKI JJ. Cardiac amyloidosis; pathology, nomenclature, and typing. Cardiovasc Pathol, 2015, 24 ( 6) ; 343-350.

MIGRINORQ. TRURAN S, GUTTERMAN DD, et al. Human microvascular dysfunction and apoptotic injury induced by AL amyloidosis light chain proteins. Am J Physiol Heart Circ Physiol,2011,301(6); H2305-H2312.

BHOGAL S, LADIA V, SITWALA P, et al. Cardiac amyloidosis; an updated review with emphasis on diagnosis and future directions. Curr Probl Cardiol,2018,43( 1); 10-34.

KOYAMA J. DAVIDOFF R, FAI.K RH. Longitudinal myocardial velocity gradient derived from pulsed Doppler tissue imaging in AL amyloidosis; a sensitive indicator of systolic and diastolic dysfunction. J Am Soc Echocardiogr. 2004,17(1);36-44.

HU K, LIU D. SALINGER T, et al. Value of cardiac biomarker measurement in the differential diagnosis of infiltrative cardiomyopathy patients with preserved left ventricular systolic function. J Thorac Dis, 2018, 10 ( 8 ) ; 4966-4975.


Refbacks

  • There are currently no refbacks.